Command Palette

Search for a command to run...

godavari-drugs

81.99+1.30%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Godavari Drugs Ltd. remains a laggard in growth and profitability compared to its peers in the Pharmaceuticals & Drugs industry. While its valuation metrics suggest it is inexpensive, it shows no earnings or revenue growth, making it a high-risk choice. In the current landscape, companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. demonstrate strong financial health and growth potential, standing out as leaders in the sector.

Key Points
  • Godavari Drugs Ltd. shows no growth or profitability metrics, making it a risky investment.
  • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. are top performers with strong EPS and ROE.
  • Value picks include Cipla and Dr. Reddy’s due to low PEG ratios and solid earnings growth.
Top Performers
Cipla Ltd.

Strong EPS growth (66.76), low PEG (0.35), and solid ROE (16.63%) with competitive margins.

Dr. Reddy's Laboratories Ltd.

High EPS growth (68.07), low PEG (0.19), and strong profitability metrics (ROE 21.76%).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.